ABC Money
Home

Thai PM defends generic drug stance despite US worries


Published :
Thu, 03 May 2007 09:23
By : Agencies
Print this Story


AddThis Social Bookmark Button

BANGKOK (XFN-ASIA) - Thai prime minister Surayud Chulanont defended his government's move to allow generic versions of three patented drugs, despite US worries over intellectual property rights in the kingdom.

'We still defend what we have done, and we can explain our action to other countries as well the world community,' Surayud told reporters.

Health minister Mongkol Na Songkhla will travel to the United States on Tuesday, along with the head of the Thai Food and Drugs Administration, to sign an agreement with the Clinton Foundation on obtaining cheaper drugs, Surayud said.

Mongkol will again travel to Washington on May 21 to explain Thailand's position to US lawmakers and other government agencies, he added.

In an annual report released on Monday, the US trade office said it was concerned by 'an overall deterioration in the protection and enforcement of intellectual property rights in Thailand.'

Apart from rampant copyright violations on books, DVDs and apparel here, the US report said Thailand's generic drug efforts were 'further indications of a weakening of respect for patents.'

Some 30 Thai activists protested today outside the US embassy here to condemn the report.

The activists accused the US Trade Representative's office of grouping Thailand with copyright offenders such as China, Russia and India in retaliation for the government's decision to allow generic versions of AIDS drugs and heart medication.

So-called compulsory licenses are allowed under World Trade Organization rules so that countries can temporarily suspend patent protections on medicines to safeguard public health.

Thailand has issued compulsory licenses for AIDS drugs Kaletra and Efavirenz and popular heart disease medicine Plavix. The government plans to import generic versions of the drugs from India, but could also choose to manufacture the drugs itself.

afp/net




Share on


 You Might Like
Thailand rejects US copyright offenders watchlist downgrade over drug row
Thai pharma group calls for dialogue on generic drug row
+
Thai activists call for boycott of US drugmaker over generics row
Mylan gets deadline extension in case

Comment on this Article
Comment:
Title:
Name:
Please Enter
 
Here
  

 Search News

 Look For
Business
Credit cards
Finance
Loans
Money
Mortgages

 
 Stock Quotes *
SYMBOL
LAST
CHANGE
DOW JONES
10340.69
-107.24 ( -1.03 %)
NASDAQ
2792.28
22.57 ( 0.81 %)
FTSE 100
5741.15
38.78 ( 0.68 %)

SYMBOL ( 2012-01-19 )
LAST
CHANGE
STANDARD CHARTERED ( 11:35am )
1559.00
70.00 ( 4.76 %)
WOLSELEY PLC ( 11:35am )
2250.00
70.00 ( 3.20 %)
CARNIVAL ( 11:35am )
2017.00
46.00 ( 2.42 %)
LAND SECURITIES GROUP ( 11:35am )
679.50
36.50 ( 5.63 %)
WHITBREAD ( 11:35am )
1662.99
33.99 ( 2.09 %)

SYMBOL ( 2012-01-19 )
LAST
CHANGE
3M COMPANY ( 12:34pm )
85.78
0.71 ( 0.83 %)
BOEING CO ( 12:34pm )
75.70
0.64 ( 0.85 %)
JP MORGAN CHASE CO ( 12:34pm )
37.03
0.49 ( 1.33 %)
WAL MART STORES ( 12:34pm )
60.44
0.43 ( 0.72 %)
IBM ( 12:34pm )
181.50
0.43 ( 0.24 %)

SYMBOL ( 2012-01-19 )
LAST
CHANGE
F5 NETWORKS INC ( 12:11pm )
122.38
13.92 ( 11.80 %)
ICO GLOBAL COMM CL A ( 8:01pm )
99999999.99
9.37 ( 366.02 %)
PRICELINECOM INC ( 12:23pm )
525.40
6.57 ( 1.26 %)
AMAZONCOM INC ( 12:04pm )
195.65
6.21 ( 3.25 %)
MILLICOM INTERNATIONAL CELLULAR SA ( 4:00pm )
110.18
4.82 ( 4.43 %)

Gainers & Losers
Dow Jones
Euro Stoxx 50
FTSE 100
FTSE 250
FTSE AIM
FTSE ALL
Nasdaq

 Portfolio Manager

You must log in to access this area of the site. If you are not a registered user click here to sign up for instant access!


 Finance Explained

Money making ideas

Save money

Money management
Savings accounts
Investing money
Share dealing
Stock broker
Forex currency trading
Pension plans
Functions of Money

(c) 2007 ABCmoney.co.uk, All Rights Reserved
*ABCMoney.co.uk does not guarantee the accuracy of any share prices or stock quotations displayed. These are not real time quotes; all are delayed by at least twenty minutes and are for information purposes only.